HU204520B - Process for producing pharmaceutically active compounds and pharmaceutical compositions containing them - Google Patents

Process for producing pharmaceutically active compounds and pharmaceutical compositions containing them Download PDF

Info

Publication number
HU204520B
HU204520B HU873600A HU360087A HU204520B HU 204520 B HU204520 B HU 204520B HU 873600 A HU873600 A HU 873600A HU 360087 A HU360087 A HU 360087A HU 204520 B HU204520 B HU 204520B
Authority
HU
Hungary
Prior art keywords
compound
formula
alkyl
phenyl
minutes
Prior art date
Application number
HU873600A
Other languages
English (en)
Hungarian (hu)
Other versions
HUT46684A (en
Inventor
Peter Thaddeus Gallagher
Terence Alan Hicks
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Publication of HUT46684A publication Critical patent/HUT46684A/hu
Publication of HU204520B publication Critical patent/HU204520B/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/44Acylated amino or imino radicals
    • C07D277/46Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/66Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/36Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyrrole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Cephalosporin Compounds (AREA)
HU873600A 1986-08-08 1987-08-07 Process for producing pharmaceutically active compounds and pharmaceutical compositions containing them HU204520B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868619433A GB8619433D0 (en) 1986-08-08 1986-08-08 Pharmaceutical compounds

Publications (2)

Publication Number Publication Date
HUT46684A HUT46684A (en) 1988-11-28
HU204520B true HU204520B (en) 1992-01-28

Family

ID=10602474

Family Applications (1)

Application Number Title Priority Date Filing Date
HU873600A HU204520B (en) 1986-08-08 1987-08-07 Process for producing pharmaceutically active compounds and pharmaceutical compositions containing them

Country Status (20)

Country Link
US (1) US4983619A (pt)
EP (1) EP0259972B1 (pt)
JP (1) JPS63246364A (pt)
CN (1) CN1021050C (pt)
AT (1) ATE91489T1 (pt)
AU (1) AU605498B2 (pt)
CA (1) CA1290335C (pt)
DE (1) DE3786507T2 (pt)
DK (1) DK414087A (pt)
EG (1) EG18231A (pt)
ES (1) ES2058118T3 (pt)
GB (1) GB8619433D0 (pt)
HU (1) HU204520B (pt)
IL (1) IL83433A (pt)
MX (1) MX173324B (pt)
NZ (1) NZ221353A (pt)
PH (1) PH23488A (pt)
PT (1) PT85477B (pt)
SU (1) SU1593568A3 (pt)
ZA (1) ZA875812B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5001124A (en) * 1990-02-02 1991-03-19 Syntex (U.S.A.) Inc. 4-isoxazolecarboxamide derivatives
US5108999A (en) * 1990-02-02 1992-04-28 Syntex (U.S.A.) Inc. 4-isoxazolecarboxamide derivatives
US5494911A (en) * 1990-05-18 1996-02-27 Hoechst Aktiengesellschaft Isoxazole-4-carboxamides and hydroxyalkylidenecyanoacetamides, pharmaceuticals containing these compounds and their use
JPH06135948A (ja) * 1992-10-30 1994-05-17 Taiho Yakuhin Kogyo Kk スチレン誘導体又はその塩
CA2185448A1 (en) * 1994-03-14 1995-09-21 James L. Mulshine Use of lipoxygenase inhibitors as anti-cancer therapeutic and intervention agents
JP2016537360A (ja) 2013-11-22 2016-12-01 ジェンザイム・コーポレーション 神経変性疾患を治療するための新規な方法
WO2021050556A1 (en) * 2019-09-09 2021-03-18 Rutgers, The State University Of New Jersey Compositions and methods for inhibiting ribosome inactivating proteins

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL186239B (nl) * 1975-06-05 Hoechst Ag Werkwijze voor de bereiding van een geneesmiddel met antiflogistische en/of analgetische werking, alsmede werkwijze voor de bereiding van een 2-hydroxyethylideencyaanazijnzuuranilide geschikt voor toepassing bij deze werkwijze.
DK545976A (da) * 1975-12-11 1977-06-12 Hoechst Ag Cyaneddikesyreanilidderivater fremgangsmade til deres fremstilling og midler der indeholder disse forbindelser
DE2655009A1 (de) * 1976-12-04 1978-06-15 Hoechst Ag Isoxazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel
GB1598900A (en) * 1978-05-23 1981-09-23 Lilly Industries Ltd Heterocyclic amino derivatives
FI71129C (fi) * 1979-06-11 1986-11-24 Ciba Geigy Ag Foerfarande foer framstaellning av farmaceutiskt aktiva alfakarbamoylpyrrolpropionitriler
DE3331874A1 (de) * 1982-09-13 1984-04-05 Sandoz-Patent-GmbH, 7850 Lörrach Neue thiophenderivate
DE3609542A1 (de) * 1986-03-21 1987-10-01 Bayer Ag 5-acylamino-pyrazol-derivate

Also Published As

Publication number Publication date
EP0259972A2 (en) 1988-03-16
CA1290335C (en) 1991-10-08
AU7668087A (en) 1988-02-11
MX7667A (es) 1993-09-01
DE3786507T2 (de) 1993-11-11
EP0259972A3 (en) 1990-05-02
ATE91489T1 (de) 1993-07-15
ES2058118T3 (es) 1994-11-01
US4983619A (en) 1991-01-08
NZ221353A (en) 1990-04-26
DK414087D0 (da) 1987-08-07
ZA875812B (en) 1989-04-26
IL83433A0 (en) 1988-01-31
PT85477B (pt) 1990-06-29
EP0259972B1 (en) 1993-07-14
DE3786507D1 (de) 1993-08-19
EG18231A (en) 1992-10-30
MX173324B (es) 1994-02-16
SU1593568A3 (ru) 1990-09-15
HUT46684A (en) 1988-11-28
PH23488A (en) 1989-08-16
CN87105515A (zh) 1988-03-23
PT85477A (en) 1987-09-01
GB8619433D0 (en) 1986-09-17
DK414087A (da) 1988-02-09
CN1021050C (zh) 1993-06-02
JPS63246364A (ja) 1988-10-13
IL83433A (en) 1992-03-29
AU605498B2 (en) 1991-01-17

Similar Documents

Publication Publication Date Title
DK175824B1 (da) Styrylpyrazoler,-isoxazoler og analoge forbindelser farmaceutiske præparater med aktivitet mod 5-lipoxygenase eller cyclooxygenase eller............
CA2029372C (fr) Derives du 1,2-benzisoxazole, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
US4110337A (en) Triazolobenzodiazepines
TW199152B (pt)
CZ288527B6 (cs) Derivát benzofuranu, benzothiofenu, indolu nebo indolizinu, způsob jejich přípravy, jejich použití a farmaceutický prostředek, který je obsahuje
CA2068261A1 (en) Urea derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
TW446704B (en) Naphtho[2,3-B]heteroar-4-yl derivatives for treating metabolic disorders related to insulin resistance or hyperglycemia
JPH06271545A (ja) ヘテロ環含有カルボン酸誘導体
JPH06500557A (ja) ロイコトリエン生合成を阻害するインドール誘導体
HU198030B (en) Process for production of derivatives of benzotiasole and benzotiophen and medical preparatives containing these compounds as active substance
US4517188A (en) 1-Pyrimidinyloxy-3-hetaryl-alkylamino-2-propanols
US4194003A (en) New pyrrole derivatives, process for their preparation and therapeutic applications thereof
JP2007197324A (ja) 2,4,5−置換−1,3−アゾール誘導体
HU190023B (en) Process for producing imidazoline derivatives and non toxic salts thereof
KR970011580B1 (ko) 항알레르기 활성을 갖는 신규의 벤조티오펜
HU204520B (en) Process for producing pharmaceutically active compounds and pharmaceutical compositions containing them
JPH05148226A (ja) ライノウイルスによりひき起こされる感染の治療に適した新規な合成化合物
JPH0222059B2 (pt)
US5187175A (en) 2-carbonyl substituted-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents
US6255498B1 (en) Method for synthesizing diaryl-substituted heterocyclic compounds, including tetrahydrofurans
WO1999016763A1 (fr) Derive de cetone et son utilisation en medecine
US4097582A (en) 6',2-(2'-Arylchromonyl) propionic acids, and analgesic and anti-inflammatory derivatives thereof
US4122200A (en) 6',2-(2'Arylchromonyl) propionic acids, and analgesic and anti-inflammatory derivatives thereof
CA1070320A (en) 3-(5-aryl-2-furyl)-3-hydroxypropionic acids and ethyl esters
CA1338844C (en) Thiophene carboxamine derivatives and their use as pharmaceuticals

Legal Events

Date Code Title Description
HMM4 Cancellation of final prot. due to non-payment of fee